These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11882786)

  • 21. Cystic fibrosis, Duchenne muscular dystrophy and preimplantation genetic diagnosis.
    Liu J; Lissens W; Devroey P; Liebaers I; Van Steirteghem A
    Hum Reprod Update; 1996; 2(6):531-9. PubMed ID: 9111186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current Status of Genetic Diagnosis Laboratories and Frequency of Genetic Variants Associated with Cystic Fibrosis through a Newborn-Screening Program in Turkey.
    Bozdogan ST; Mujde C; Boga I; Sonmezler O; Hanta A; Rencuzogullari C; Ozcan D; Altintas DU; Bisgin A
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33572515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testing and reporting ACMG cystic fibrosis mutation panel results.
    Lebo RV; Grody WW
    Genet Test; 2007; 11(1):11-31. PubMed ID: 17394390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active cascade testing for carriers of cystic fibrosis gene.
    Super M; Schwarz MJ; Malone G; Roberts T; Haworth A; Dermody G
    BMJ; 1994 Jun; 308(6942):1462-7. PubMed ID: 8019278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CFTR allelic heterogeneity in Mexican patients with cystic fibrosis: implications for molecular screening.
    Chávez-Saldaña M; Yokoyama E; Lezana JL; Carnevale A; Macías M; Vigueras RM; López M; Orozco L
    Rev Invest Clin; 2010; 62(6):546-52. PubMed ID: 21416780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Sensitivity of Cystic Fibrosis Mutation Panels in a Diverse Population.
    Hughes EE; Stevens CF; Saavedra-Matiz CA; Tavakoli NP; Krein LM; Parker A; Zhang Z; Maloney B; Vogel B; DeCelie-Germana J; Kier C; Anbar RD; Berdella MN; Comber PG; Dozor AJ; Goetz DM; Guida L; Kattan M; Ting A; Voter KZ; ; van Roey P; Caggana M; Kay DM
    Hum Mutat; 2016 Feb; 37(2):201-8. PubMed ID: 26538069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cystic fibrosis screening at the Greenville Hospital System.
    Dacus J; Mabie B; Gailey T; Rogers C; Likes C; Metcalf L
    J S C Med Assoc; 2006 Feb; 102(1):14-6. PubMed ID: 16704181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cystic fibrosis heterozygote screening in 5,161 pregnant women.
    Witt DR; Schaefer C; Hallam P; Wi S; Blumberg B; Fishbach A; Holtzman J; Kornfeld S; Lee R; Nemzer L; Palmer R
    Am J Hum Genet; 1996 Apr; 58(4):823-35. PubMed ID: 8644747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystic fibrosis screening: lessons learned from the first 320,000 patients.
    Strom CM; Crossley B; Redman JB; Buller A; Quan F; Peng M; McGinnis M; Sun W
    Genet Med; 2004; 6(3):136-40. PubMed ID: 15354331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystic fibrosis mutation testing in Italy.
    Bombieri C; Pignatti PF
    Genet Test; 2001; 5(3):229-33. PubMed ID: 11788089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The CFTR variant profile of Hispanic patients with cystic fibrosis: Impact on access to effective screening, diagnosis, and personalized medicine.
    Januska MN; Marx L; Walker PA; Berdella MN; Langfelder-Schwind E
    J Genet Couns; 2020 Aug; 29(4):607-615. PubMed ID: 32227567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An update on cystic fibrosis screening.
    Goetzinger KR; Cahill AG
    Clin Lab Med; 2010 Sep; 30(3):533-43. PubMed ID: 20638569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted extended cystic fibrosis mutation testing on known and at-risk patients and relatives.
    Lebo RV; Omlor GJ
    Genet Test; 2007; 11(4):427-44. PubMed ID: 18294061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Four case reports of Chinese cystic fibrosis patients and literature review.
    Xu J; Yin Y; Zhang L; Zhang J; Yuan S; Zhang H
    Pediatr Pulmonol; 2017 Aug; 52(8):1020-1028. PubMed ID: 28608624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A universal array-based multiplexed test for cystic fibrosis carrier screening.
    Amos JA; Bridge-Cook P; Ponek V; Jarvis MR
    Expert Rev Mol Diagn; 2006 Jan; 6(1):15-22. PubMed ID: 16359263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis: newborn screening in America.
    Kleven DT; McCudden CR; Willis MS
    MLO Med Lab Obs; 2008 Jul; 40(7):16-8, 22, 24-7. PubMed ID: 18717498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience of an academic reference laboratory using automation for analysis of cystic fibrosis mutations.
    DeMarchi JM; Beaudet AL; Caskey CT; Richards CS
    Arch Pathol Lab Med; 1994 Jan; 118(1):26-32. PubMed ID: 8285831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The D1152H cystic fibrosis mutation in prenatal carrier screening, patients and prenatal diagnosis.
    Peleg L; Karpati M; Bronstein S; Berkenstadt M; Frydman M; Yonath H; Pras E
    J Med Screen; 2011; 18(4):169-72. PubMed ID: 22156145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Genetics Society of Australasia position statement: population-based carrier screening for cystic fibrosis.
    Delatycki MB; Burke J; Christie L; Collins F; Gabbett M; George P; Haan E; Ioannou L; Martin N; McKenzie F; O'Leary P; Scoble-Williams N; Turner G; Massie J;
    Twin Res Hum Genet; 2014 Dec; 17(6):578-83. PubMed ID: 25431289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation screening for prenatal and presymptomatic diagnosis: cystic fibrosis and haemochromatosis.
    Stuhrmann M; Graf N; Dörk T; Schmidtke J
    Eur J Pediatr; 2000 Dec; 159 Suppl 3():S186-91. PubMed ID: 11216897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.